SAN DIEGO, Nov. 11, 2010 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of contract development and manufacturing services for biopharmaceutical and parenteral products, announced today that Rick Hancock has been appointed President of the company. Mr. Hancock brings twenty-seven years of industry experience and detailed working knowledge of Althea's operations to lead the company into the future. Mr. Hancock will lead the company's expansion of its clinical and commercial contract manufacturing services.
Dr. Magda Marquet, Co-Founder and Co-Chairman of the Board, commented, "I am very confident that Rick's proven track record and leadership style will be integral to Althea's growth and success as we continue to expand our business into commercial operations. I am delighted to see Rick appointed as President."
Mr. Hancock was Althea's Chief Operating Officer from 1998 to 2007. In addition, he served as Althea's Executive Vice President, Europe to expand Althea's global presence. During his tenure as Althea's COO, Rick was instrumental in growing the company from a small group of scientists and manufacturing staff to a leading contract manufacturing organization. In addition, Mr. Hancock has a very strong background in process development and GMP manufacturing dating back to his tenure at Hybritech, The Immune Response Corporation and Genetics Institute.
Commenting on the contributions of his predeces